Skip to main content

Table 1 Demographic and Treatment Characteristics (N = 102)

From: Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients

Variable N (%)
Age (Mean, SD, Median) 57.0 (13.5) 57
Ethnicity  
   Caucasian 73 (71.6%)
   African American 26 (25.5%)
   Other 2 (2.0%)
   Unknown 1 (1.0%)
BMI (Mean, SD, Median) 29.0 (6.5) 28.0
Had Prior Breast Cancer Surgery 89 (87.3%)
Had Prior Radiation Therapy 73 (71.6%)
Had Prior Neoadjuvant Therapy 16 (15.7%)
Had Prior Adjuvant Therapy 63 (61.8%)
First Line Therapy  
   None Reported 4 (3.9%)
   Hormonal Therapy Only 30 (29.4%)
   Taxane Based Therapy 43 (42.0%)
   Non-Taxane Based Therapy 25 (25.0%)
   Had Toxicity Related Discontinuation 7 (6.9%)
Received Second Line Therapy 92 (90.1%)
   Had Toxicity Related Discontinuation 6 (6.5%)